aledade.comHealthcare / Healthcare providers & servicesFounded: 2014Funding to Date: $696.82MM
Aledade is a healthcare company that partners with independent, primary care physicians to provide everything the doctors need to create and run an Accountable Care Organization (ACO) – from business and practice transformation services to upfront capital and a cutting-edge technology platform.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/21/2023 | Series F | $260MM | $xx.xx | $3.52B | Lightspeed Venture Partners, Venrock, Avidity Partners, OMERS Growth Equity, Fidelity | |
Price per Share
$xx.xx
Shares Outstanding
5,187,804
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Lightspeed Venture Partners, Venrock, Avidity Partners, OMERS Growth Equity, Fidelity
|
||||||
06/06/2022 | Series E-3 | $30MM | $xx.xx | $3.14B | OMERS Growth Equity, Fidelity | |
Price per Share
$xx.xx
Shares Outstanding
602,235
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OMERS Growth Equity, Fidelity
|
||||||
06/06/2022 | Series E-2 | $10.29MM | $xx.xx | $3.14B | OMERS Growth Equity, Fidelity | |
Price per Share
$xx.xx
Shares Outstanding
242,984
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OMERS Growth Equity, Fidelity
|
||||||
06/06/2022 | Series E-1 | $92.27MM | $xx.xx | $3.14B | OMERS Growth Equity, Fidelity | |
Price per Share
$xx.xx
Shares Outstanding
1,852,227
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OMERS Growth Equity, Fidelity
|
||||||
01/19/2021 | Series D | $100.25MM | $xx.xx | $2.37B | Meritech Capital Partners, Tiger Global Management, IVP, OMERS Growth Equity | |
Price per Share
$xx.xx
Shares Outstanding
2,618,130
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Meritech Capital Partners, Tiger Global Management, IVP, OMERS Growth Equity
|
||||||
04/20/2020 | Series C | $67.33MM | $xx.xx | $735.89MM | OMERS Growth Equity, California Medical Association, Meritech Capital Partners, Echo Health Ventures, CVF, GV | |
Price per Share
$xx.xx
Shares Outstanding
5,206,094
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OMERS Growth Equity, California Medical Association, Meritech Capital Partners, Echo Health Ventures, CVF, GV
|
||||||
01/18/2019 | Series B-2 | $56.15MM | $xx.xx | $411.08MM | Echo Health Ventures, Meritech Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
7,126,806
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Echo Health Ventures, Meritech Capital Partners
|
||||||
03/08/2017 | Series B-1 | $45.25MM | $xx.xx | $207.68MM | Biomatics Capital, GV, Maryland Venture Fund, Venrock, McKesson Ventures, ARCH Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
8,262,765
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Biomatics Capital, GV, Maryland Venture Fund, Venrock, McKesson Ventures, ARCH Venture Partners
|
||||||
06/15/2015 | Series B | $30.25MM | $xx.xx | $135.88MM | ARCH Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
5,954,491
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
ARCH Venture Partners
|
||||||
06/18/2014 | Series A | $5.04MM | $xx.xx | $16.79MM | Venrock | |
Price per Share
$xx.xx
Shares Outstanding
4,744,293
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Venrock
|